BioCentury
ARTICLE | Company News

Quanterix raises $18.5M, in deal with bioMerieux

November 16, 2012 1:52 AM UTC

Quanterix Corp. (Cambridge, Mass.) raised $18.5 million in a series C round led by bioMerieux S.A. (Euronext:BIM). Existing investors Arch Venture Partners, Bain Capital Ventures; and Flagship Ventures also participated, along with In-Q-Tel. Quanterix also granted bioMerieux exclusive, worldwide rights to Quanterix's single-molecule array (Simoa) technology for clinical laboratories and industrial applications. Quanterix will develop a new instrument based on the Simoa technology, and bioMerieux will develop ultra-sensitive and multiplex assays for use on the new instrument. Quanterix will receive an undisclosed upfront payment and is eligible for milestones and royalties. On Thursday, bioMerieux was off EUR 0.29 to EUR 69.23. ...